Search

Search Constraints

You searched for: Author/Creator Hilpert, Felix

Search Results

1. 2022-RA-276-ESGO Value of surgical cytoreduction for subsequent ovarian cancer relapse in patients previously treated with chemotherapy alone at 1st-relapse: a subanalysis of the DESKTOP III/ENGOT-ov20 trial. (20th October 2022)

2. 2022-RA-285-ESGO Real world data of treatment and outcome of patients with early ovarian cancer (FIGO I) in Germany (QS Ovar of the AGO Study Group). (20th October 2022)

3. 2022-RA-420-ESGO Treatment and outcome of patients with high-grade advanced ovarian cancer (AOC) – real world data of the german quality assurance project (QS Ovar of the AGO Study Group). (20th October 2022)

4. 2022-RA-798-ESGO Diagnosis of first relapse and its impact on quality of life in patients with advanced ovarian cancer (AGO-OVAR 19/II). (20th October 2022)

6. Accelerating type‐specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high‐throughput tool for case review. Issue 5 (2nd September 2013)

8. Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study. Issue 7 (28th May 2020)

9. Association between obesity and vulvar cancer recurrence: an analysis of the AGO‐CaRE‐1 study. Issue 7 (July 2020)

10. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial. Issue 5 (May 2020)